header.html

An official website of the European Union How do you know?      
European Commission logo

handle.jsp

cover
A Case Study
Use of high-throughput, in vitro bioactivity data in setting a point-of-departure (POD) has the potential to accelerate the pace of human health safety evaluation by informing screening-level assessments. The primary objective of this work was to compare PODs based on high-throughput predictions of bioactivity, exposure predictions, and traditional hazard information for 448 chemicals. PODs derived from new approach methodologies (NAMs) were obtained for this comparison using the 50th (PODNAM, 50) and the 95th (PODNAM, 95) percentile credible interval estimates for the steady-state plasma concentration used in in vitro to in vivo extrapolation of administered equivalent doses. Of the 448 substances, 89% had a PODNAM, that was less than the traditional POD (PODtraditional) value.
2022-01-28
OXFORD UNIV PRESS
JRC117500
1096-6080 (online),   
https://academic.oup.com/toxsci/article/173/1/202/5571376,    https://publications.jrc.ec.europa.eu/repository/handle/JRC117500,   
10.1093/toxsci/kfz201 (online),   
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 

footer.html